These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 27278221)

  • 1. Pharmacologic Approaches to Electrolyte Abnormalities in Heart Failure.
    Grodin JL
    Curr Heart Fail Rep; 2016 Aug; 13(4):181-9. PubMed ID: 27278221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Hyperkalemia in Heart Failure and the Therapeutic Use of Potassium Binders.
    Sarwar CMS; Bhagat AA; Anker SD; Butler J
    Handb Exp Pharmacol; 2017; 243():537-560. PubMed ID: 28382468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Managing Hyperkalemia: Stepping Into a New Frontier.
    Pham AQ; Sexton J; Wimer D; Rana I; Nguyen T
    J Pharm Pract; 2017 Oct; 30(5):557-561. PubMed ID: 27609505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure and electrolyte disturbances.
    Schwinger RH; Erdmann E
    Methods Find Exp Clin Pharmacol; 1992 May; 14(4):315-25. PubMed ID: 1507935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in treatment of hyperkalemia in chronic kidney disease.
    Sarafidis PA; Georgianos PI; Bakris GL
    Expert Opin Pharmacother; 2015; 16(14):2205-15. PubMed ID: 26330193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute Management of Hyperkalemia.
    Liu M; Rafique Z
    Curr Heart Fail Rep; 2019 Jun; 16(3):67-74. PubMed ID: 30972536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging therapies for the management of chronic hyperkalemia in the ambulatory care setting.
    Henneman A; Guirguis E; Grace Y; Patel D; Shah B
    Am J Health Syst Pharm; 2016 Jan; 73(2):33-44. PubMed ID: 26721532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperkalemia in Heart Failure.
    Sarwar CM; Papadimitriou L; Pitt B; Piña I; Zannad F; Anker SD; Gheorghiade M; Butler J
    J Am Coll Cardiol; 2016 Oct; 68(14):1575-89. PubMed ID: 27687200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exchangeable electrolytes in heart disease.
    Olesen KH
    Acta Med Scand Suppl; 1981; 647():47-60. PubMed ID: 7020348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloride in Heart Failure: The Neglected Electrolyte.
    Zandijk AJL; van Norel MR; Julius FEC; Sepehrvand N; Pannu N; McAlister FA; Voors AA; Ezekowitz JA
    JACC Heart Fail; 2021 Dec; 9(12):904-915. PubMed ID: 34857174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium Zirconium Cyclosilicate (ZS-9): A Novel Agent for the Treatment of Hyperkalemia.
    Linder KE; Krawczynski MA; Laskey D
    Pharmacotherapy; 2016 Aug; 36(8):923-33. PubMed ID: 27393581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium zirconium cyclosilicate (ZS-9) for the treatment of hyperkalemia.
    Rafique Z; Peacock WF; LoVecchio F; Levy PD
    Expert Opin Pharmacother; 2015; 16(11):1727-34. PubMed ID: 26159448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral sodium and potassium binders in heart failure.
    Morris AA; Cole RT; Butler J; Gupta D
    Curr Heart Fail Rep; 2015 Apr; 12(2):107-11. PubMed ID: 25542216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetazolamide therapy for hypochloremic metabolic alkalosis in pediatric patients with heart disease.
    Moffett BS; Moffett TI; Dickerson HA
    Am J Ther; 2007; 14(4):331-5. PubMed ID: 17667206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Basic Metabolic Profile in Heart Failure-Marker and Modifier.
    Elfar A; Sambandam KK
    Curr Heart Fail Rep; 2017 Aug; 14(4):311-320. PubMed ID: 28674911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral administration of a potent carbonic anhydrase inhibitor ("Diamox"). I. Changes in electrolyte and acid-base balance.
    Leaf A; Schwartz WB; Relman AS
    N Engl J Med; 1954 May; 250(18):759-64. PubMed ID: 13165895
    [No Abstract]   [Full Text] [Related]  

  • 18. Sodium zirconium cyclosilicate: a new potassium binder for the treatment of hyperkalemia.
    Cases A; Gorriz JL
    Drugs Today (Barc); 2018 Oct; 54(10):601-613. PubMed ID: 30398481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetazolamide as a potent chloride-regaining diuretic: short- and long-term effects, and its pharmacologic role under the 'chloride theory' for heart failure pathophysiology.
    Kataoka H
    Heart Vessels; 2019 Dec; 34(12):1952-1960. PubMed ID: 31114959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hyperkalemia - current therapuetic strategies].
    Głogowski T; Wojtaszek E
    Wiad Lek; 2016; 69(5):745-748. PubMed ID: 28033600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.